Lu Timothy - 27 Jan 2023 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
CMO
Signature
/s/ Scott Robertson as attorney-in-fact for Timothy Lu
Issuer symbol
N/A
Transactions as of
27 Jan 2023
Net transactions value
$0
Form type
4
Filing time
31 Jan 2023, 16:37:39 UTC
Previous filing
19 Apr 2022
Next filing
05 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 27 Jan 2023 Common Stock 90,000 $32.31 Direct F1
transaction DICE Restricted Stock Unit (RSU) Award $0 +15,000 $0.000000 15,000 27 Jan 2023 Common Stock 15,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the total shares monthly, beginning January 27, 2023, until such time as the option is 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
F3 The RSUs vest as to 1/4th of the total shares annually, beginning January 27, 2023, until such time as the RSUs are 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.